A Study Evaluating the Safety and Tolerability of QRL-201 in ALS

Clinical trial NCT05633459 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05633459
Sponsor: QurAlis Corporation
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2022-12-16
Primary completion: 2026-05-29
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.